Therapeutic Applications of CpG-Containing Oligodeoxynucleotides

Antisense and Nucleic Acid Drug DevelopmentVol. 8, No. 2 Therapeutic Applications of CpG-Containing OligodeoxynucleotidesDENNIS M. KLINMANDENNIS M. KLINMANPublished Online:30 Jan 2009https://doi.org/10.1089/oli.1.1998.8.181AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByT Cell/B Cell Interactions in the Establishment of Protective Immunity24 September 2021 | Vaccines, Vol. 9, No. 10Mucosal Vaccines for Aged: Challenges and Struggles in ImmunosenescenceFunctional Diversity of the Soil Culturable Microbial Community in Eucalyptus Plantations of Different Ages in Guangxi, South China28 November 2019 | Forests, Vol. 10, No. 12Bio-oxidation of Elemental Mercury into Mercury Sulfide and Humic Acid-Bound Mercury by Sulfate Reduction for Hg 0 Removal in Flue Gas7 October 2019 | Environmental Science & Technology, Vol. 53, No. 21Mucosal Vaccination Challenges in Aging: Understanding Immunosenescence in the Aerodigestive Tract29 May 2019Mucosal Vaccination Challenges in Aging: Understanding Immunosenescence in the Aerodigestive Tract22 August 2018Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae13 June 2017 | Microbiology and Immunology, Vol. 61, No. 6Novel vaccine development strategies for inducing mucosal immunity9 January 2014 | Expert Review of Vaccines, Vol. 11, No. 3Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens9 January 2014 | Expert Review of Vaccines, Vol. 10, No. 2Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines9 January 2014 | Expert Review of Vaccines, Vol. 8, No. 9CpG Immunotherapy in Chenopodium album sensitized mice: The comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations17 September 2008 | Clinical and Molecular Allergy, Vol. 6, No. 1Broad-Spectrum Drugs Against Viral Agents1 September 2008 | International Journal of Molecular Sciences, Vol. 9, No. 9CpG-ODN enhances mammary gland defense during mastitis induced by Escherichia coli infection in goatsVeterinary Immunology and Immunopathology, Vol. 120, No. 3-4CpG oligonucleotides accelerate and boost the immune response elicited by AVA, the licensed anthrax vaccine9 January 2014 | Expert Review of Vaccines, Vol. 5, No. 3Adjuvant Activity of CpG Oligodeoxynucleotides3 August 2009 | International Reviews of Immunology, Vol. 25, No. 3-4Common human Toll-like receptor 9 polymorphisms and haplotypes: association with atopy and functional relevanceClinical Experimental Allergy, Vol. 35, No. 9CpG-activated Thy1.2+ dendritic cells protect against lethalListeria monocytogenes infectionEuropean Journal of Immunology, Vol. 35, No. 8Dendritic Cells Targeting Flt3 Ligand As Molecular Mucosal AdjuvantInternational Journal of Oral-Medical Sciences, Vol. 3, No. 3CpG oligonucleotides improve the protective immune response induced by the anthrax vaccination of rhesus macaquesVaccine, Vol. 22, No. 21-22Use of CpG oligodeoxynucleotides as immune adjuvantsImmunological Reviews, Vol. 199, No. 1Use of CpG oligodeoxynucleotides as immunoprotective agents23 February 2005 | Expert Opinion on Biological Therapy, Vol. 4, No. 6Immunotherapeutic uses of CpG oligodeoxynucleotidesNature Reviews Immunology, Vol. 4, No. 4CpG-induced immunomodulation and intracellular bacterial killing in a chicken macrophage cell lineDevelopmental & Comparative Immunology, Vol. 27, No. 9Antisense therapeutics: from theory to clinical practicePharmacology & Therapeutics, Vol. 99, No. 1Influence of stimulatory and suppressive DNA motifs on host susceptibility to inflammatory arthritis3 June 2003 | Arthritis & Rheumatism, Vol. 48, No. 6CpG DNA as a vaccine adjuvant9 January 2014 | Expert Review of Vaccines, Vol. 2, No. 2Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection modelJournal of Hepatology, Vol. 38, No. 3Gene and Antisense Therapy of Bladder CancerHost Immunity and Vaccine Development to Coccidia and Salmonella Infections in ChickensThe Journal of Poultry Science, Vol. 40, No. 3Antisense Oligonucleotide Therapy in UrologyJournal of Urology, Vol. 168, No. 1Antisense Oligonucleotide Therapy in UrologyThe Journal of Urology, Vol. 75DNA containing CpG motifs induces angiogenesis11 June 2002 | Proceedings of the National Academy of Sciences, Vol. 99, No. 13CpG Oligodeoxynucleotides as Vaccine Adjuvants in Primates15 February 2002 | The Journal of Immunology, Vol. 168, No. 4Phosphodiester Oligonucleotides Inhibit Mitosis and Trigger Apoptosis by a Non-Antisense, p53-Mediated Mechanism Laura Papucci, Nicola Schiavone, Martino Donnini, Andrea Lapucci, Ettore Luzi, Alessio Tempestini, Ewa Witort, and Sergio Capaccioli8 July 2004 | Antisense and Nucleic Acid Drug Development, Vol. 12, No. 1Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cellsImmunology, Vol. 105, No. 2CpG Motif Identification for Veterinary and Laboratory Species Demonstrates That Sequence Recognition Is Highly Conserved Robert Rankin, Reno Pontarollo, Xenia Ioannou, Arthur M. Krieg, Rolf Hecker, Lorne A. Babiuk, and Sylvia van Drunen Littel-van den Hurk8 July 2004 | Antisense and Nucleic Acid Drug Development, Vol. 11, No. 5Cutting Edge: Role of Toll-Like Receptor 9 in CpG DNA-Induced Activation of Human Cells1 October 2001 | The Journal of Immunology, Vol. 167, No. 7Sterically Stabilized Cationic Liposomes Improve the Uptake and Immunostimulatory Activity of CpG Oligonucleotides15 September 2001 | The Journal of Immunology, Vol. 167, No. 6Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotidesVeterinary Microbiology, Vol. 78, No. 4Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases24 February 2005 | Expert Opinion on Pharmacotherapy, Vol. 2, No. 2Activation of the innate immune system by CpG oligodeoxynucleotides: immunoprotective activity and safetyCpG Oligodeoxynucleotides Induce Murine Macrophages to Up-Regulate Chemokine mRNA ExpressionCellular Immunology, Vol. 206, No. 2DNA vaccines: a key for inducing long-term cellular immunityCurrent Opinion in Immunology, Vol. 12, No. 4Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responsesMicrobiology, Vol. 81, No. 7In Vitro and in Vivo Responses to Interleukin 12 Are Maintained until the Late SIV Infection Stage but Lost during AIDS François Villinger, Silvana Bucur, Nathaniel F. Chikkala, Sukhdev S. Brar, Pavel Bostik, Ann E. Mayne, Jonathan Adams, Mark E. Lee, Francis J. Novem, Maurice K. Gately, Aftab A. Ansari, and Christopher D. Hillyer5 July 2004 | AIDS Research and Human Retroviruses, Vol. 16, No. 8DNA Vaccines: Immunology, Application, and OptimizationAnnual Review of Immunology, Vol. 18, No. 1Oligodeoxyribonucleotides with 5′-ACGT-3′ or 5′-TCGA-3′ Sequence Induce Production of InterferonsConsequences of Bacterial CpG DNA-Driven Activation of Antigen-Presenting CellsCpG DNA Co-Stimulates Antigen-Reactive T CellsRepeated Administration of Synthetic Oligodeoxynucleotides Expressing CpG Motifs Provides Long-Term Protection against Bacterial InfectionInfection and Immunity, Vol. 67, No. 11An Antisense Oligonucleotide Primer RICHARD I. HOGREFE30 January 2009 | Antisense and Nucleic Acid Drug Development, Vol. 9, No. 4Immune Recognition of Foreign DNAImmunity, Vol. 11, No. 2Non-Antisense Oligonucleotide Approaches for Experimental Treatment of Glioblastoma LEN M. NECKERS, MEERA KANEKAL, and YVETTE CONNELL30 January 2009 | Antisense and Nucleic Acid Drug Development, Vol. 8, No. 2 Volume 8Issue 2Apr 1998 To cite this article:DENNIS M. KLINMAN.Therapeutic Applications of CpG-Containing Oligodeoxynucleotides.Antisense and Nucleic Acid Drug Development.Apr 1998.181-184.http://doi.org/10.1089/oli.1.1998.8.181Published in Volume: 8 Issue 2: January 30, 2009PDF download